Denmark· DK-28100435763
Provera
A medroxyprogesterone product containing medroxyprogesteronacetat, registered in Denmark by Pfizer ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Medroxyprogesterone is registered in 9 of 19 countries.
Countries holding a registration under ATC G03DA02 (medroxyprogesterone), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Medroxyprogesterone · ATC G03DA02
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MEDROXYPROGESTERONACETAT
- Manufacturer
- Pfizer ApS
- Country
- Denmark (DK)
- ATC code
- G03DA02
- ATC class
- Medroxyprogesterone
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28100435763
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
241 interactions on record for medroxyprogesterone.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Medroxyprogesterone · interactions on record
241 records
- 21 severe
- 213 moderate
- 7 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G03DA02
Medroxyprogesterone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7ba0c3ca-36be-4e74-bf4a-28640525878b GET /v1/drugs/7ba0c3ca-36be-4e74-bf4a-28640525878b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "5 mg",
"auth_role": "DKMA",
"dk_drugid": "28100435763",
"substance": "MEDROXYPROGESTERONACETAT",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "23424"
}See everything about medroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.